JSM 2005 - Toronto

JSM Activity #389

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
389 Applied Session Wed, 8/10/05, 10:30 AM - 12:20 PM MCC-200 G
Multiple Comparisons in Phase II Studies - Topic Contributed - Papers
Biopharmaceutical Section, WNAR
Organizer(s): Alexei Dmitrienko, Eli Lilly and Company, Brian Wiens, Amgen, Inc.
Chair(s): Brian Wiens, Amgen, Inc.
     10:35 AM   The Multistage Fallback Test for Clinical Trials with Multiple Objectives — Alexei Dmitrienko, Eli Lilly and Company; Brian Wiens, Amgen, Inc.
     10:55 AM   Adaptive Design for Dose-response Studies Using the Partitioning Principle — Jason Hsu, The Ohio State University; Xiang Ling, The Ohio State University
     11:15 AM   A Modified Tukey Linear Trend Test in Dose-Response Studies — Chao-Yin Chen, University of Minnesota; Lan Kong, University of Pittsburgh; Huei Wang, Amgen Global Biostatistics; Thomas Liu, Amgen Global Biostatistics; Brian Wiens, Amgen, Inc.
     11:35 AM   Performance of Some Multiple Testing Procedures To Compare Three Doses of a Test Drug and Placebo — Lan Kong, University of Pittsburgh; Gary G. Koch, University of North Carolina, Chapel Hill; Thomas Liu, Amgen Global Biostatistics; Huei Wang, Amgen Global Biostatistics
     11:55 AM   Multiple Inferences in Early Phase II Clinical Trials: Performance of Exact Methods for Dose Response — Alok Krishen, GlaxoSmithKline; Rafe Donahue, GlaxoSmithKline
     12:15 PM   Floor Discussion
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005